Willetts N
Biotech Australia Pty. Ltd., Roseville, Sydney.
Crit Rev Microbiol. 1994;20(2):79-85. doi: 10.3109/10408419409113547.
Because of the increasing problems of resistance to chemicals and chemical residues, preventative vaccination has increasing appeal as a way to control parasite infestations in humans and in animals. Such vaccines are now feasible through the application of genetic engineering technology to allow production of parasite protective antigens in microorganisms in commercially viable quantities at an acceptable cost. This concept is illustrated by describing research toward subunit vaccines against human malaria (P. falciparum) and against the tropical cattle tick (B. microplus). Although the concept is straightforward, difficulties include the identification of a protective antigen, refolding of the initial microbial product to achieve the native conformation, and its formulation to produce a vaccine eliciting an adequate and appropriate immune response.
由于化学药物抗性和化学残留问题日益严重,预防性疫苗作为控制人类和动物寄生虫感染的一种方式,吸引力与日俱增。如今,通过应用基因工程技术,以可接受的成本在微生物中大量生产具有商业可行性的寄生虫保护性抗原,此类疫苗已成为可能。通过描述针对人类疟疾(恶性疟原虫)和热带牛蜱(微小牛蜱)的亚单位疫苗的研究,阐述了这一概念。尽管该概念很简单,但困难包括保护性抗原的鉴定、将初始微生物产物重折叠以实现天然构象,以及将其制成能引发充分且适当免疫反应的疫苗。